Moleculera Biosciences Patient Stories
Parents fear for child’s safety after sudden and severe personality changes
At age 4, Alexia developed a strep throat infection. Within days, she began throwing violent tantrums, was removed from pre-school, started talking about suicide and was admitted to a psychiatric hospital.
Watch patients describe how the Autoimmune Brain Panel™
(formerly the Cunningham Panel™) helped changed their lives.
INVESTOR INQUIRIES
Join Moleculera Biosciences in our mission to improve the lives of those suffering from immune-mediated neuropsychiatric, cardiovascular and neurodegenerative disorders.
Investor inquiries please contact:
Craig Shimasaki, PhD, MBA President and CEO, Moleculera Biosciences shimasakic@moleculera.com
Gary Gentges Investor and Business Relations Consultant gentgesg@moleculera.com
If you would like us to contact you directly, please complete the form.